© Copyright 2020 Lundbeck. All rights reserved. UBR-C-100133v6 (D) and UBR-C-100134v6 (M)
Our utmost priority is to protect the well-being of the communities we serve and our 1,000 Lundbeck colleagues nationwide, and so we are taking responsible action within our control to limit the rapid escalation of the virus and maintain support of our provider and patient communities.
We are proud to continue to partner with healthcare professionals to serve those living with brain diseases during this unprecedented time.
Lundbeck is committed to developing and providing innovative therapies that help improve patients' lives. As part of our commitment, we work to provide appropriate assistance to patients who seek access to our therapies. The Lundbeck Patient Assistance Program (PAP) may be available to patients who have limited financial resources and who do not have insurance coverage for their medication. Eligibility criteria apply.
In this video, Lundbeck’s President and CEO, Dr. Deborah Dunsire, thanks the dedicated frontline healthcare workers who are battling the coronavirus. She also expresses gratitude for providers who manage the healthcare needs of people living with psychiatric and neurological disorders, and she shares how Lundbeck is providing support to people living with brain diseases during this unprecedented time of history.
We know that seniors and people with underlying health conditions are more likely to experience serious complications if they contract the virus. But there is another community that also is at risk and needs our attention: People living with brain diseases are especially vulnerable to the effects of stress, and stress levels are now dramatically on the rise. For people who live with existing mental health conditions such as depression, bipolar disorder or schizophrenia, or neurological conditions such as migraine, increased stress could lead to a relapse or serious worsening of symptoms.